scPharmaceuticals Inc. Overview
Pro stress-test →scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. Its commercial product, FUROSCIX, consists of furosemide delivered via an on-body infuser.
Strategic Profile
Pro stress-test →The company's strategy is to develop therapies for subcutaneous administration that have previously been limited to intravenous (IV) delivery. MannKind Corporation has completed its acquisition of scPharmaceuticals, with scPharmaceuticals showing impressive revenue growth of 107.79% over the last twelve months.
Competitive Landscape
Pro stress-test →scPharmaceuticals operates in the specialized drug delivery market, competing with other companies developing subcutaneous administration technologies. The acquisition by MannKind positions it within a larger pharmaceutical ecosystem focused on innovative delivery mechanisms.
Industry Context
scPharmaceuticals Inc. operates in Specialty Pharmaceuticals / Drug Delivery Systems.
Key facts
Revenue: 107.79% growth (LTM)